Immune Response Gene Polymorphisms and Cervical Cancer Susceptibility
- 1Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University, 71-252 Szczecin, Poland
Abstract
Cervical cancer (CxCa) remains one of the most common malignancies in women worldwide. Although almost all cases are associated with chronic infection with oncogenic human papillomavirus (HPV) types, not every infected woman develops the disease, indicating a significant role of genetic factors. This study reviewed 131 studies on genes related to immune system function and their impact on the risk of developing cervical cancer. The majority of the studies analyzed were conducted in Asian populations, primarily Chinese and Indian. The analysis focused in particular on polymorphisms in genes involved in the antiviral response, inflammatory processes, antigen presentation, and regulation of lymphocyte activity. Most of the evidence points to the importance of human leukocyte antigens (HLA) genes, Toll-like receptors (TLRs), interleukins (ILs), tumor necrosis factor alpha (TNF-α), and interferons (IFNs). Variants in these genes may influence the effectiveness of HPV clearance, susceptibility to persistent infection, and the risk of progression of precancerous lesions to invasive cancer. It is worth emphasizing that identifying genetic risk factors may, in the future, support the development of personalized prevention strategies, screening tests, and the assessment of the individual risk of disease. Nevertheless, most available findings warrant further validation in large and diverse populations. In summary, cervical cancer is the result of a complex interaction between HPV infection and the host’s genetic predisposition. Research on immune response genes provides valuable information about the mechanisms of disease development, and may contribute to improved methods of prevention and early detection.
Related
- Durable complete response to tislelizumab in advanced pMMR cervical cancer and successful rechallenge after immune-related NSTEMI: a case report.
- Advances in γδ T cell-mediated immune surveillance in cervical cancer
- Radiomics modeling to predict the tumor immune-microenvironment of mucinous adenocarcinoma of gastric-type cervical cancer
- Integrated Genomic and Immune Profiling Reveals PIK3CA-Mutant HPV16-Positive Cervical Cancer as a Clinically Aggressive and Immunologically Distinct Subtype in Patients from Eastern India
- ASSESSMENT OF TREATMENT RESPONSE RESPONSE AND THE ROLE OF COMPLETION SURGERY AFTER CONCURRENT CRTAND BRACHYTHERAPY FOR LOCALLY ADVANCED CERVICAL CANCER - A REVIEW FROM THE FRENCH CERVICAL CANCER GUIDELINES GROUP
BibTeX
@article{dwornik2026immune,
title = {{Immune Response Gene Polymorphisms and Cervical Cancer Susceptibility}},
author = {Roksana Dwornik and Dagmara Cylwik and Katarzyna Białkowska},
journal = {International Journal of Molecular Sciences},
year = {2026},
month = oct,
doi = {10.3390/ijms27209384},
url = {https://www.mdpi.com/1422-0067/27/20/9384},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Immune Response Gene Polymorphisms and Cervical Cancer Susceptibility
AU - Roksana Dwornik
AU - Dagmara Cylwik
AU - Katarzyna Białkowska
PY - 2026
DA - 2026/10/21
JO - International Journal of Molecular Sciences
DO - 10.3390/ijms27209384
UR - https://www.mdpi.com/1422-0067/27/20/9384
AB - Cervical cancer (CxCa) remains one of the most common malignancies in women worldwide. Although almost all cases are associated with chronic infection with oncogenic human papillomavirus (HPV) types, not every infected woman develops the disease, indicating a significant role of genetic factors. This study reviewed 131 studies on genes related to immune system function and their impact on the risk of developing cervical cancer. The majority of the studies analyzed were conducted in Asian populations, primarily Chinese and Indian. The analysis focused in particular on polymorphisms in genes involved in the antiviral response, inflammatory processes, antigen presentation, and regulation of lymphocyte activity. Most of the evidence points to the importance of human leukocyte antigens (HLA) genes, Toll-like receptors (TLRs), interleukins (ILs), tumor necrosis factor alpha (TNF-α), and interferons (IFNs). Variants in these genes may influence the effectiveness of HPV clearance, susceptibility to persistent infection, and the risk of progression of precancerous lesions to invasive cancer. It is worth emphasizing that identifying genetic risk factors may, in the future, support the development of personalized prevention strategies, screening tests, and the assessment of the individual risk of disease. Nevertheless, most available findings warrant further validation in large and diverse populations. In summary, cervical cancer is the result of a complex interaction between HPV infection and the host’s genetic predisposition. Research on immune response genes provides valuable information about the mechanisms of disease development, and may contribute to improved methods of prevention and early detection.
SN - 1422-0067
ER -